Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
17.60
-0.26 (-1.46%)
May 20, 2026, 11:44 AM CST

SHE:000623 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
20,93922,89720,65317,09817,02021,034
Market Cap Growth
12.09%10.86%20.79%0.46%-19.09%10.96%
Enterprise Value
20,51022,28320,12616,96116,15819,596
Last Close Price
17.8619.5316.8013.9113.5216.33
PE Ratio
7.639.5613.3111.719.5611.81
PS Ratio
9.409.817.914.965.939.13
PB Ratio
0.660.740.710.620.650.84
P/TBV Ratio
0.670.760.720.640.660.86
P/FCF Ratio
182.93159.22--111.321821.95
P/OCF Ratio
92.2484.10347.21251.2240.1564.75
EV/Sales Ratio
9.219.547.714.925.638.51
EV/EBITDA Ratio
-859.61431.7249.9149.4997.79
EV/EBIT Ratio
---126.08124.383339.39
EV/FCF Ratio
179.19154.95--105.681697.40
Debt / Equity Ratio
0.070.070.080.110.110.10
Debt / EBITDA Ratio
36.6946.3630.898.238.4112.45
Debt / FCF Ratio
19.6515.57--19.56226.58
Net Debt / Equity Ratio
-0.02-0.02-0.01-0.01-0.03-0.08
Net Debt / EBITDA Ratio
-16.64-27.93-8.28-1.02-2.68-10.08
Net Debt / FCF Ratio
-5.66-5.031.800.99-5.73-174.93
Asset Turnover
0.070.070.080.110.100.08
Inventory Turnover
1.411.461.772.021.931.95
Quick Ratio
1.941.981.571.082.253.89
Current Ratio
2.382.401.961.292.704.35
Return on Equity (ROE)
8.83%7.85%5.35%5.37%7.01%7.29%
Return on Assets (ROA)
-0.27%-0.31%-0.31%0.27%0.27%0.01%
Return on Invested Capital (ROIC)
-0.48%-0.55%-0.57%0.49%0.54%0.03%
Return on Capital Employed (ROCE)
-0.40%-0.50%-0.50%0.50%0.40%0.00%
Earnings Yield
13.11%10.46%7.51%8.54%10.46%8.46%
FCF Yield
0.55%0.63%-1.04%-2.06%0.90%0.06%
Dividend Yield
2.81%2.56%2.98%4.31%2.22%1.84%
Payout Ratio
23.62%27.10%68.33%27.44%21.21%14.36%
Buyback Yield / Dilution
1.47%0.34%9.08%0.46%-3.36%1.39%
Total Shareholder Return
4.28%2.90%12.06%4.77%-1.14%3.22%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.